Table 3.
Characteristics of recurrent cases.
| Case | Tumor size (mm) | Histology (size in mm) |
LVSI | DSI | Surgery | Time to recurrence | Recur site | Recur Tx | Outcome (after recurrence) |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 20 (on CE) | SCC, G1 (10) |
Neg | Neg | LRT | 3 months | Cervix | CCRT | NED at 63 months |
| 2 | 17 (on MRI) | SCC, G2 (15) |
Neg | Neg | LRT | 16 months | Carcinomatosis | CT | DOD at 14 months |
| 3 | 23 (on MRI) | SCC, G2 (10) |
Neg | Pos | LRT | 8 months | Cervix | Sx + RT + BT | NED at 73 months |
| 4 | 22 (on MRI) | AC, G1 (7) |
Pos | Neg | LRT | 77 months | Cervix and ovary | Sx + CT | NED at 3 months |
| 5 | 20 (on EP) | AC, G1 (11) |
Neg | Neg | LRT | 12 months | Ovary | Sx + CT | NED at 51 months |
| 6 | 25 (on MRI) | AC, G1 (24) |
Neg | Neg | ORT | 5 months | Pelvis | CCRT | DOD at 14 months |
LVSI, lymphovascular space invasion; DSI, deep stromal invasion; Tx, treatment; CE, clinical examination; MRI, magnetic resonance imaging; EP, excisional procedure; SCC, squamous cell carcinoma; AC, adenocarcinoma; Neg, negative; POS, positive; LRT, laparoscopic radical trachelectomy; ORT, open radical trachelectomy; CCRT, concurrent chemoradiation; CT, chemotherapy; Sx, surgery; RT, radiotherapy; BT, brachytherapy.